TEM's Genomics unit is expected to report strong growth for the first quarter, banking on continued unit growth pick-up.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Analysts are estimating that Avantor will report an earnings per share (EPS) of $0.23. Avantor bulls will hope to hear the ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $63.78, ...

Tempus AI (TEM) announced multi-year, strategic collaborations with AstraZeneca (AZN) and Pathos AI, Inc., in which the companies will work ...

BTIG analyst Mark Massaro has initiated coverage on Tempus AI (TEM), with a Buy rating and a price target of $60, implying 48 ...

Tempus AI reports 30.4% YoY revenue growth in FY2024, driven by genomics and data services. Discover key metrics and ...

Illumina Inc. and Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a collaboration to accelerate clinical adoption of ...

This story originally appeared in Talk of the Town, a weekly newsletter of local stories that dig deep, events, and more from the Spotlight PA State College bureau ...

Neither federal nor state open records laws allow the public to access their elected leaders’ work calendars. At the federal level, the Freedom of Information Act applies only to agencies and ...

Tempus Unveils Advisory Board Featuring Leading Physicians From Across the U.S. Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...